Market Overview

Morning Market Losers


Regado Biosciences (NASDAQ: RGDO) dropped 57.10% to $2.90 following the announcement of halt of patient enrollment in REGULATE-PCI trial. Wedbush downgraded Regado Biosciences from Outperform to Underperform.

NQ Mobile (NYSE: NQ) shares slipped 29.59% to $4.76 after the company announced certain changes to its Board of Directors and provided a status update on its 2013 annual audit.

Tekmira Pharmaceuticals (NASDAQ: TKMR) tumbled 14.23% to $11.81 after the company received notice of clinical hold for TKM-Ebola Phase I clinical trial from the FDA.

BIND Therapeutics (NASDAQ: BIND) shares declined 9.16% to $11.70 after the company reported the closing of collaboration deal with Amgen (NASDAQ: AMGN).

Real Goods Solar (NASDAQ: RGSE) fell 8.39% to $2.66 as the company priced 2.92 million units at $2.40 per unit.

SYNNEX (NYSE: SNX) dipped 4.13% to $70.88 after the company issued a downbeat outlook for the third quarter. It expected adjusted earnings of $1.45 to $1.50 per share on revenue of $3.3 billion to $3.4 billion. Analysts were projecting earnings of $1.53 per share on revenue of $3.29 billion.

Posted-In: market losersNews Movers & Shakers Intraday Update Markets


Related Articles (AMGN + BIND)

View Comments and Join the Discussion!

TheStreet's David Peltier On Investing In Stocks Under $10, Picking Dividends And Apple

UPDATE: Janney Capital Downgrades Trimble Navigation As Ag Cyclicality Dampens Growth, Multiple Expectations